Metastatic cancers: Targeting a protein that fuels treatment-resistant tumors may be key to better outcomes
One of the biggest challenges in cancer treatment is addressing the ability of cancer cells to adapt and become resistant, reducing the effectiveness of therapies over time.
Potential new therapy for childhood brain cancer could heal treatment-resistant tumors
Brain cancer is the second-leading cause of death in children in the developed world. For the children who survive, standard treatments have long-term impacts on their development and quality of life, particularly in small children and infants.
For detailed information on these approvals, you can refer to the FDA’s official page on novel drug approvals for 2024.
Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti-cancer immune response after initiation of a personalized cancer vaccine.
Using light to monitor high blood pressure and cancer treatment
Using light to monitor high blood pressure and cancer treatment
Making Strides Toward Off-the-Shelf CAR T Cell Therapy for Cancer
A new advance may make it possible to use off-the-shelf CAR T cells provided by healthy donors. The new approach studied in mice equipped CAR T cells with the viral protein Nef.
Nanosystem Offers Precision Targeting and Therapy for Tongue Cancer
Researchers have developed a new nanosystem that provides precision targeting and therapy for tongue cancer, potentially improving treatment outcomes.
Peanuts may help cancer spread, study finds
Peanuts may help cancer spread, study finds
Huntsman Cancer Institute leads the way with advanced robotic surgery technology
Huntsman Cancer Institute at the University of Utah (the U) proudly announces the addition of two da Vinci 5 robotic surgical systems.
New research unlocks key to long-lasting immune response in cancer and chronic diseases
Prolonged illnesses like cancer and chronic infections often leave the immune system in a state of exhaustion, where its frontline defenders — T cells — lose their ability to function effectively. Researchers have identified a rare type of immune cells, called stem-like T cells, that holds the key to maintaining powerful, long-term immune responses.
Study finds stem-like T cells key to lasting immune response in cancer, chronic diseases
Prolonged illnesses like cancer and chronic infections often leave the immune system in a state of exhaustion, where its frontline defenders—T cells—lose their ability to function effectively. Research, led by the Peter Doherty Institute for Infection and Immunity (Doherty Institute) and the Peter MacCallum Cancer Center (Peter Mac), have identified a rare type of immune cells, called stem-like T cells, that holds the key to maintaining powerful, long-term immune responses.
Accelerating Cancer Treatment with Precision Medicine & NGS
Asia accounts for nearly half of global cancer cases, making it a major health concern. Recognising the promise of precision oncology, governments across the region have initiated efforts to drive advancements in this space. Let’s take a closer look at the progress being made in precision oncology in the Asia Pacific region.
AI Tailors Cancer Treatment to Individual Patients
A novel AI tool from BIFOLD and partner institutions deciphers complex cancer interrelationships, enhancing personalized medicine and clinical decision-making.
